Marex Group stake now 0% for JRJ-related holders
Marex Group plc received an amended Schedule 13G filing from JRJ Investor 1 LP, Amphitryon Limited (in liquidation), JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff regarding Marex common stock, par value $0.001551 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marex Group plc received an amended Schedule 13G filing from JRJ Investor 1 LP, Amphitryon Limited (in liquidation), JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff regarding Marex common stock, par value $0.001551 per share. The filing states that Amphitryon Limited directly holds 0 shares of Marex and that JRJ Investor 1 LP, JRJ Group Limited, Sir Jeremy Isaacs and Mr. Roger Nagioff may previously have been deemed to share beneficial ownership of shares once held by Amphitryon Limited.
The group now reports 0 shares with 0% of the class, and no sole or shared voting or dispositive power over Marex common stock. The filing confirms they are owners of 5 percent or less of this class of securities.
Key Figures
Key Terms
beneficial ownership financial
Schedule 13G regulatory
sole voting power financial
dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change does the Schedule 13G/A report for Marex Group plc (MRX)?
Who are the reporting persons in the Marex Group plc (MRX) Schedule 13G/A?
What percentage of Marex Group plc (MRX) does the JRJ group report owning?
What security is covered in this Marex Group plc (MRX) Schedule 13G/A?
Where are the JRJ reporting entities for Marex Group plc (MRX) organized?
AI-generated analysis. How Rhea-AI works. Not financial advice.